Director Shareholding

GlaxoSmithKline PLC
14 July 2003


                              Directors' Interests

I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.

10 July 2003                 The Administrators of the SmithKline Beecham 
                             Employee Benefit Trust ("the Trust") notified the 
                             Company on the 14 July 2003 that 1,474 Ordinary 
                             shares had been purchased for participants in the 
                             SmithKline Beecham Bonus Investment Plan at a price 
                             of £11.985 per share on 10 July 2003.

                             The Trust also notified the Company on 14 July 2003 
                             that 4,437 Ordinary shares had been purchased for 
                             participants in the GlaxoSmithKline Annual
                             Investment Plan on 10 July 2003 at a price of 
                             £11.985 per share.

The Trust is a discretionary fund of which all employees or former employees of
GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of the
Company's directors, Dr J P Garnier and John Coombe are therefore interested in
the shares held in the fund from time to time in the same way as other employees
or former employees of GlaxoSmithKline plc and its subsidiaries.

S M Bicknell
Company Secretary


14 July 2003



                      This information is provided by RNS
            The company news service from the London Stock Exchange